A provider of automation and analytics solutions for healthcare systems, the company specializes in medication management and adherence technologies. Its products are widely used in hospitals and pharmacies, making it a key player in optimizing medication workflows. Investors monitor its performance due to its role in addressing inefficiencies in healthcare delivery.
3 members of Congress have disclosed 6 trades in Omnicell, Inc. (OMCL), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 5 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-04-09 | Sara Jacobs | sell | $50K – $100K |
| 2017-12-19 | JAMES B. RENACCI | sell | $1K – $15K |
| 2017-12-19 | JAMES B. RENACCI | buy | $1K – $15K |
| 2015-12-08 | JAMES B. RENACCI | sell | $1K – $15K |
| 2015-05-14 | JAMES B. RENACCI | sell | $1K – $15K |
| 2015-02-13 | Thomas R Tillis | sell | $1K – $15K |